SpringerLink
Log in

Thrombolytic Therapy in Acute Pulmonary Embolism

  • Chapter
  • First Online:
Controversies in Critical Care

Abstract

In patients with acute pulmonary embolism, thrombolytic therapy leads to a rapid reduction of the clot burden and relieves obstruction to pulmonary blood flow. However, the benefits of therapy must be balanced against the prospect of bleeding complications that may lead to adverse outcomes. This chapter reviews the utility of thrombolytic therapy in acute pulmonary embolism with varying levels of severity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
EUR 29.95
Price includes VAT (Germany)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
EUR 117.69
Price includes VAT (Germany)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
EUR 117.69
Price includes VAT (Germany)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info
Hardcover Book
EUR 160.49
Price includes VAT (Germany)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sherry S. The origin of thrombolytic therapy. J Am Coll Cardiol. 1989;14(4):1085–92.

    Article  CAS  PubMed  Google Scholar 

  2. Sautter RD, Emanuel DA, Fletcher FW, Wenzel FJ, Matson JI. Urokinase for the treatment of acute pulmonary thromboembolism. JAMA. 1967;202(3):215–8.

    Article  CAS  PubMed  Google Scholar 

  3. Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, et al. ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Respir J. 2019;54(3):1901647. Available from: https://erj.ersjournals.com/content/54/3/1901647

    Article  PubMed  Google Scholar 

  4. Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e419S–96S.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Urokinase pulmonary embolism trial. Phase 1 results: a cooperative study. JAMA. 1970;214(12):2163–72.

    Google Scholar 

  6. Dotter CT, Seaman AJ, Rösch J, Porter JM. Streptokinase and heparin in the treatment of pulmonary embolism: a randomized comparison. Vasc Surg. 1979;13(1):42–52.

    Article  Google Scholar 

  7. Ly B, Arnesen H, Eie H, Hol R. A controlled clinical trial of streptokinase and heparin in the treatment of major pulmonary embolism. Acta Med Scand. 1978;203(6):465–70.

    CAS  PubMed  Google Scholar 

  8. Jerjes-Sanchez C, Ramírez-Rivera A, de Lourdes GM, Arriaga-Nava R, Valencia S, Rosado-Buzzo A, et al. Streptokinase and heparin versus heparin alone in massive pulmonary embolism: a randomized controlled trial. J Thromb Thrombol. 1995;2(3):227–9.

    Article  CAS  Google Scholar 

  9. Stein PD, Matta F. Thrombolytic therapy in unstable patients with acute pulmonary embolism: saves lives but underused. Am J Med. 2012 May;125(5):465–70.

    Article  PubMed  Google Scholar 

  10. Chatterjee S, Chakraborty A, Weinberg I, Kadakia M, Wilensky RL, Sardar P, et al. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis. JAMA. 2014;311(23):2414–21.

    Article  PubMed  Google Scholar 

  11. Marti C, John G, Konstantinides S, Combescure C, Sanchez O, Lankeit M, et al. Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. Eur Heart J. 2015;36(10):605–14.

    Article  CAS  PubMed  Google Scholar 

  12. Goldhaber SZ, Haire WD, Feldstein ML, Miller M, Toltzis R, Smith JL, et al. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet. 1993;341(8844):507–11.

    Article  CAS  PubMed  Google Scholar 

  13. Konstantinides S, Geibel A, Heusel G, Heinrich F, Kasper W. Management strategies and prognosis of pulmonary Embolism-3 trial investigators. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med. 2002;347(15):1143–50.

    Article  CAS  PubMed  Google Scholar 

  14. Fasullo S, Scalzo S, Maringhini G, Ganci F, Cannizzaro S, Basile I, et al. Six-month echocardiographic study in patients with submassive pulmonary embolism and right ventricle dysfunction: comparison of thrombolysis with heparin. Am J Med Sci. 2011;341(1):33–9.

    Article  PubMed  Google Scholar 

  15. Meyer G, Vicaut E, Danays T, Agnelli G, Becattini C, Beyer-Westendorf J, et al. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med. 2014;370(15):1402–11.

    Article  CAS  PubMed  Google Scholar 

  16. Kline JA, Steuerwald MT, Marchick MR, Hernandez-Nino J, Rose GA. Prospective evaluation of right ventricular function and functional status 6 months after acute submassive pulmonary embolism: frequency of persistent or subsequent elevation in estimated pulmonary artery pressure. Chest. 2009;136(5):1202–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Wang C, Zhai Z, Yang Y, Wu Q, Cheng Z, Liang L, et al. Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial. Chest. 2010;137(2):254–62.

    Article  CAS  PubMed  Google Scholar 

  18. Sharifi M, Bay C, Skrocki L, Rahimi F, Mehdipour M. “MOPETT” investigators. Moderate pulmonary embolism treated with thrombolysis (from the “MOPETT” trial). Am J Cardiol. 2013;111(2):273–7.

    Article  PubMed  Google Scholar 

  19. Zhang Z, Zhai Z-g, Rong LL, Fang LF, Hua YY, Wang C. Lower dosage of recombinant tissue-type plasminogen activator (rt-PA) in the treatment of acute pulmonary embolism: a systematic review and meta-analysis. Thromb Res. 2014;133(3):357–63.

    Article  CAS  PubMed  Google Scholar 

  20. Yilmaz ES, Uzun O. Low-dose thrombolysis for submassive pulmonary embolism. J Investig Med. 2021;69(8):1439–46.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Halaby R, Giri J. Keep it simple? Half-dose systemic thrombolysis or catheter-directed thrombolysis for pulmonary embolism. Vasc Med. 2019;24(2):110–1.

    Article  PubMed  Google Scholar 

  22. Kuo WT, Banerjee A, Kim PS, DeMarco FJ, Levy JR, Facchini FR, et al. Pulmonary embolism response to fragmentation, embolectomy, and catheter thrombolysis (PERFECT): initial results from a prospective multicenter registry. Chest. 2015;148(3):667–73.

    Article  PubMed  Google Scholar 

  23. Kucher N, Boekstegers P, Müller OJ, Kupatt C, Beyer-Westendorf J, Heitzer T, et al. Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation. 2014;129(4):479–86.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Critical Care Medicine, Narayana Health, Bangalore, Karnataka, India

    Jose Chacko

  2. Intensive Care, St George Hospital, Sydney, NSW, Australia

    Swapnil Pawar

  3. Intensive Care Medicine, Nepean Hospital, Sydney, NSW, Australia

    Ian Seppelt

  4. Critical Care Medicine, Aster RV Hospital, Bangalore, Karnataka, India

    Gagan Brar

Authors
  1. Jose Chacko
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Swapnil Pawar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ian Seppelt
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gagan Brar
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Chacko, J., Pawar, S., Seppelt, I., Brar, G. (2023). Thrombolytic Therapy in Acute Pulmonary Embolism. In: Controversies in Critical Care. Springer, Singapore. https://doi.org/10.1007/978-981-19-9940-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-981-19-9940-6_14

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-19-9939-0

  • Online ISBN: 978-981-19-9940-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation